Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival

Journal of Pediatric Hematology/Oncology

Volumn 21, Issue 3, 1999, Pages 181-189

  DuBois, Steven G ^a   Kalika, Yan ^a   Lukens, John N ^b   Brodeur, Garrett M ^c   Seeger, Robert C ^d   Atkinson, James B ^g   Haase, Gerald M ^e   Black, C Thomas ^f   Perez, Carlos ^g   Shimada, Hiroyuki ^d   Gerbing, Robert ^h   Stram, Daniel O ^h   Matthay, Katherine K ^a,h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e CHILDREN S HOSPITAL   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

Age; Metastasis; MYCN; Neuroblastoma; Survival

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; BONE MARROW METASTASIS; BONE METASTASIS; BRAIN METASTASIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CHILD; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; NEUROBLASTOMA; PRIORITY JOURNAL;

ADOLESCENT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; NEOPLASM METASTASIS; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYC; SURVIVAL ANALYSIS;

EID: 0033509949     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199905000-00005     Document Type: Article

References (29)

1. Brodeur GM, Castlebery RP. Neuroblastoma. In: Pizzo PA, Poplack DG, eds. Principles and practice of pediatric oncology, 3rd ed. Philadelphia: Lippincott, 1997:761-97.
2. Matthay KK. Neuroblastoma. In: Pochedly C, ed. Neoplastic diseases in childhood. Chur, Switzerland: Harwood, 1994:735-78.
3. D'Angio GJ, Evans AE, Koop CE. Special pattern of widespread neuroblastoma with a favourable prognosis. Lancet 1971;1: 1046-9.
4. Daubenton JD, Fisher RM, Karabus CD, et al. The relationship between prognosis and scintigraphic evidence of bone metastases in neuroblastoma. Cancer 1987;59:1586-9.
5. Labreveux de Cervens C, Hartmann O, Bonnin F, et al. What is the prognostic value of osteomedullary uptake on MIBG scan in neuroblastoma patients under one year of age? Med Pediatr Oncol 1994;22:107-14.
6. Nakagawara A, Morita K, Okabe I, et al. Proposal and assessment of Japanese Tumor Node Metastasis postsurgical histopathological staging system for neuroblastoma based on an analysis of 495 cases. Jpn J Clin Oncol 1991;21:1-7.
7. Moss TJ, Reynolds CP, Sather HN, et al. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 1991;324:219-26.
8. Stephenson SR, Cook BA, Mease AD, et al. The prognostic significance of age and pattern of metastases in stage IV-S neuroblastoma. Cancer 1986;58:372-5.
9. Berthold F, Trechow R, Utsch S, et al. Prognostic factors in metastatic neuroblastoma. Am J Pediatr Hematol Oncol 1992;14:207-15.
10. Rosen EM, Cassady R, Frantz CN, et al. Stage IV-N: a favorable subset of children with metastatic neuroblastoma. Med Pediatr Oncol 1985;13:194-8.
11. Hann HWL, Evans AE, Siegel SE, et al. Prognostic importance of serum ferritin in patients with stages III and IV neuroblastoma: the Children's Cancer Study Group experience. Cancer Res 1985;45: 2843-8.
12. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985;313:1111-6.
13. Shimada H, Chatten J, Newton WA, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984;73:405-16.
14. Matthay KK, Perez C, Seeger RC, et al. Successful treatment for stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group Study. J Clin Oncol 1998;16:1256-64.
15. Brodeur GM, Seeger RC, Schwab M, et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121-4.
16. Seeger RC, Wada R, Brodeur GM, et al. Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene. Prog Clin Biol Res 1988;271:41-9.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
18. Cowie F, Corbett R, Pinkerton CR. Lung involvement in neuroblastoma: incidence and characteristics. Med Pediatr Oncol 1997; 28:429-32.
19. Towbin R, Gruppo RA. Pulmonary metastases in neuroblastoma. Am J Roentgenol 1982;138:75-8.
20. Carlsen NLT, Schroeder H, Christensen IJ, et al. Signs, symptoms, metastatic spread and metabolic behavior of neuroblastomas treated in Denmark during the period 1943-1980. Anticancer Res 1987;7:465-74.
21. Blatt J, Fitz C, Mirro JR. Recognition of central nervous system metastases in children with metastatic primary extracranial neuroblastoma. Pediatr Hematol Oncol 1997;14:233-41.
22. Kellie SJ, Hayes FA, Bowman L, et al. Primary extracranial neuroblastoma with central nervous system metastases: characterization by clinicopathologic findings and neuroimaging. Cancer 1991;68:1999-2006.
23. Shaw PJ, Eden T. Neuroblastoma with intracranial involvement: an ENSG Study. Med Pediatr Oncol 1992;20:149-55.
24. Vannucci RC, Baten M. Cerebral metastatic disease in childhood. Neurology 1974;24:981-5.
25. Tsuchida Y, Yokomori K, Saito S, et al. Stage IV-S neuroblastoma involving the liver and ectopic liver. Cancer 1984;53:1609-11.
26. Kuwashima N. Organ-specific adhesion of neuroblastoma cells in vitro: correlation with their hepatic metastasis potential. J Pediatr Surg 1997;32:546-51.
27. Gross N, Beretta C, Peruisseau G, et al. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Cancer Res 1994;54:4238-42.
28. Favrot MC, Combaret V, Goillot E, et al. Expression of integrin receptors on 45 clinical neuroblastoma specimens. Int J Cancer 1991;49:347-55.
29. Leone A, Seeger RC, Hong CM, et al. Evidence for nm23 RNA overexpression. DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 1993;8:855-65.